Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: The logo of Belgian drug, chemical, and plastics group UCB is seen at the entrance of the company's headquarters in ...

NEW YORK (Reuters) - Belgian pharmaceutical company UCB (UCB.BR) is exploring a sale of its Kremers Urban Pharmaceuticals Inc division, a U.S. speciality generics business that could fetch as much as ...

Weeks after Belgium's UCB announced that it would sell its U.S. generic drug business for $1.53 billion, the company is calling off the sale in light of regulatory pushback over one of the unit's ...

Brussels (Belgium) - November 17, 2009 - Press Release - UCB announced today its intention to make organizational changes in some divisions at its sites in Braine-l'Alleud (Belgium) and Slough (UK).

PARIS/SINGAPORE, Aug 26 (Reuters) - UCB, a Belgian biopharmaceutical firm, said on Monday it would sell its Chinese neurology and allergy business to Singapore-based asset management group CBC and Abu ...

Biogen Inc.’s stock was slightly lower Tuesday, shedding early gains made after the company and Belgian partner UCB announced positive results in a late-stage trial of a treatment for the chronic ...

(Reuters) - UCB has agreed to acquire U.S.-based Ra Pharmaceuticals for $2.1 billion, both companies reported on Thursday, in a deal that will enable the Belgian drugmaker to offer new treatment ...